LON:BVXP
Bioventix PLC
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
1492.00p
Buy <=wait / entry
1233.33p
Trim >=take some off
1500.00p
Thesis breakThe thesis would be invalidated by the loss of a named major IVD customer, by di...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 23% | 100 / 100 | 23.0 |
| Base case | 47% | 62 / 100 | 29.1 |
| Bear case | 30% | 10 / 100 | 3.0 |
| Weighted conviction | 55 / 100 - OPPORTUNISTIC BUY | ||
Top risks
- Revenue decline of 3.61% year-on-year to 13.12m with net income down 6.33% to 7.58m
- Customer concentration risk (HIGH) as a sub-GBP100m company with concentrated IVD customer base
- Product concentration and lifecycle risk (MEDIUM) where a small number of antibodies drive disproportionate revenue